Regulation of the MDR1 promoter by cyclic AMP-dependent protein kinase and transcription factor Sp1

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 383-386

  Rohlff, Christian ^a,c   Glazer, Robert I ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c Oxford GlycoSciences   (United Kingdom)

Author keywords

Cyclic AMP; Multidrug resistance; Promoter; Protein kinase

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; TRANSCRIPTION FACTOR SP1;

ARTICLE; ENANTIOMER; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GENE AMPLIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

EID: 0031932166     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.2.383     Document Type: Article

References (30)

1. Bosch I and Croop J: P-glycoprotein multidrug resistance and cancer. Biochim Biophys Acta 1288: F37-F54, 1996.
2. Hill BT: Drug resistance: an overview of the current state of the art. Int J Oncol 9: 197-203, 1996.
3. Bellamy WT: P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol 36: 161-183, 1996.
4. Chen C-J, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM and Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 P-glycoprotein gene from multidrug-resistant human cells. Cell 47: 381-389, 1986.
5. Gros P, Croop J and Housman DE: Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380, 1986.
6. Ueda K, Cardarelli C, Gottesman MM and Pastan I: Expression of full-length cDNA for the human 'MDR1' gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84: 3004-3008, 1987.
7. Fairchild CR, Ivy SP, Kao-Shan C-S, Whang-Peng J, Rosen N, Israel MA, Melera PW, Cowan KH and Goldsmith ME: Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res 47: 5141-5148, 1987.
8. Shen D-W, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I and Gottesman MM: Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 232: 643-645, 1986.
9. Fuqua SAW, Moretti-Rojas IM, Schneider SL and McGuire WL: P-glycoprotein expression in human breast cancer cells. Cancer Res 47: 2103-2106, 1987.
10. Hennequin E, Delvincourt C, Pourny C and Jardillier JC: Expression of mdr1 gene in human breast primary tumours and metastases. Breast Cancer Res Treat 26: 267-274, 1993.
11. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, von Hoff DD and Roninson IB: Quantitative analysis of the MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164, 1990.
12. Abraham I, Chin KV, Gottesman MM and Sampson KE: Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase causes increased drug sensitivity and decreased expression of P-glycoprotein. Exp Cell Res 189: 133-141, 1990.
13. Chin KV, Chauhan SS, Abraham I, Sampson KE, Krolczyk AJ, Wong M, Schimmer B, Pastan I and Gottesman MM: Reduced mRNA levels for the multidrug-resistance genes in cAMP-dependent protein kinase mutant cell lines. J Cell Physiol 152: 87-94, 1992.
14. Kim SH, Park JI, Chung BS, Kang CD and Hidaka H: Inhibition of MDR1 gene expression by H-87, a selective inhibitor of cAMP-dependent protein kinase. Cancer Lett 74: 37-41, 1993.
15. Cho-Chung YS, Clair T, Tagliaferri P, Ally S, Katsaros D, Tprtora G, Neckers L, Avery TL, Crabtree GW and Robins RK: Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation. Cancer Invest 7: 161-177, 1989.
16. Tagliaferi P, Katsaros D, Clair T, Ally S, Tortora G, Neckers L, Rubalcava B, Parandoosh Z, Chang YA, Revankar GR, Crabtree GW, Robins RK and Cho-Chung YS: Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues. Cancer Res 48: 1642-1650, 1988.
17. Rohlff C, Clair T and Cho-Chung YS: 8-Cl-cAMP induces truncation and downregulation of the RI subunit and upregulation of the RII subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J Biol Chem 268: 5774-5782, 1993.
18. Scala S, Budillon A, Zhan Z, Cho-Chung YS, Jefferson J, Tsokos M and Bates SE: Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J Clin Invest 96: 1026-1034, 1995.
19. Handshin JC and Eppenberger U: Altered cellular ratio of type I and type II cyclic AMP-dependent protein kinase in human mammary tumors. FEBS Lett 106: 301-304, 1979.
20. Miller WR, Watson DMA, Jack W, Chetty U and Elton RA: Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer. Breast Cancer Res Treat 26: 89-94, 1993.
21. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D and Boyd MR: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48: 4827-4833, 1988.
22. Goldsmith ME, Madden CS, Morrow CS and Cowan KH: A Y-box consensus sequence is required for basal expression of the human multidrug resistance (MDR1) gene. J Biol Chem 268: 5856-5860, 1993.
23. Ahmad S, Trepel JB, Ohno S, Suzuki K, Tsuruo T and Glazer RI: The role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin. Mol Pharmacol 42: 1004-1009, 1992.
24. He Y, Borellini F, Koch WH, Huang K-X and Glazer RI: Transcriptional regulation of c-Fes in myeloid leukemia cells. Biochim Biophys Acta 1306: 179-186, 1996.
25. Rohlff C, Ahmad S, Borellini F, Lei J and Glazer RI: Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J Biol Chem 272: 21137-21141, 1997.
26. Ogura M, Takatori T and Tsuruo T: Purification and characterization of NF-R1 that regulates the expression of the human multidrug resistance (AWR1) gene. Nucleic Acids Res 20: 5811-5817, 1992.
27. Madden CS, Morrow CS, Nakagawa M, Goldsmith ME, Fairchild CR and Cowan KH: Identification of the 5' and 3' sequences involved in the regulation of the transcription of the human MDR1 gene in vivo. J Biol Chem 268: 8290-8297, 1993.
28. Imagawa M, Chiu R and Karin M: Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51: 251-260, 1987.
29. Chiu R, Imagawa M, Imbra RJ, Bockoven JR and Karin M: Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature 329: 648-651, 1987.
30. Cornwell MM and Smith DE: SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J Biol Chem 268: 19505-19511, 1993.